Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Lifecore Biomedical Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
LFCR
Nasdaq
2834
https://www.lifecore.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Lifecore Biomedical Inc
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
- Mar 26th, 2024 8:30 pm
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
- Mar 21st, 2024 4:40 pm
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
- Mar 20th, 2024 11:30 am
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
- Mar 20th, 2024 11:00 am
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
- Feb 16th, 2024 9:05 pm
Strength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?
- Feb 6th, 2024 2:49 pm
Should You Hold Lifecore Biomedical (LFCR) for Long Term?
- Jan 30th, 2024 5:20 am
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
- Jan 12th, 2024 9:43 pm
Even after rising 12% this past week, Lifecore Biomedical (NASDAQ:LFCR) shareholders are still down 39% over the past five years
- Jan 10th, 2024 11:05 am
Here’s Why Cove Street Capital Reduced its Position in Lifecore Biomedical (LFCR)
- Jan 8th, 2024 8:05 am
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
- Jan 5th, 2024 1:00 pm
Lifecore Biomedical Provides Business Update
- Dec 13th, 2023 12:30 pm
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
- Nov 20th, 2023 9:05 pm
Here’s Why Lifecore Biomedical (LFCR) Declined in Q3
- Oct 24th, 2023 11:48 am
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
- Oct 18th, 2023 8:05 pm
SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement
- Oct 17th, 2023 9:00 am
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
- Oct 10th, 2023 8:05 pm
Here’s Why Cove Street Capital Sold Lifecore Biomedical (LFCR)
- Oct 10th, 2023 12:43 pm
Will Lifecore Biomedical (LFCR) Report Negative Q1 Earnings? What You Should Know
- Sep 28th, 2023 2:00 pm
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2023 Earnings Call Transcript
- Sep 1st, 2023 2:44 pm
Scroll